ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NRBO NeuroBo Pharmaceuticals Inc

3.78
0.05 (1.34%)
May 04 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -4.58M-2.88M-3.22M-3.1M-10.43M-2.52M-3.81M-3.89M
Pre Tax Income -4.58M-2.88M-3.3M-3.11M-4.68M-2.6M-734k-3.82M
Net Income -4.58M-2.88M-3.3M-3.11M-4.68M-2.6M-734k-3.82M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -4.58M-2.88M-3.3M-3.19M-10.42M-2.52M-3.81M-3.89M
EBITDA -4.57M-2.86M-3.21M-3.1M-10.43M-2.52M-3.81M-3.89M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -14.7M-33.12M-22.81M-20.18M-29.72M-15.3M-19.63M-15.89M
Pre Tax Income -14.59M-33.42M-23.64M-21.31M-29.68M-15.28M-13.97M-12.47M
Net Income -14.95M-33.42M-23.64M-21.31M-29.68M-15.28M-13.97M-12.47M
Preferred Dividends -366k0000000
Basic Earnings Per Share (EPS) -1.613-3.143-1.657-1.367-1.509-0.573-0.549-0.321
EBIT -14.7M-33.13M-22.98M-21.29M-29.72M-15.3M-19.71M-15.89M
EBITDA -14.7M-33.12M-22.81M-20.16M-29.67M-15.25M-19.61M-15.88M

Your Recent History

Delayed Upgrade Clock